Chiranjit (Ghani Khan Choudhury Institute of Engineering & Technology Sain West Bengal India),Atanu (National Institute of Technology Banerjee Meghalaya India.),Pabitra Kumar (NIT MIZORAM Biswas INDIA
（1）
Response-adaptive designs, which aim to reduce the number of patients receiving inferior treatments, are becoming increasingly popular in Phase III clinical trials. Written by leading experts, Respons
